Literature DB >> 10720819

Antibodies to enteric adenoviruses (Ad40 and Ad41) in sera from Iranian children.

H Saderi1, M H Roustai, F Sabahi.   

Abstract

BACKGROUND: There is strong epidemiologic and serologic evidence that infection with the enteric adenoviruses can result in severe gastroenteritis in children.
OBJECTIVES: This study was performed to determine the prevalence of enteric adenovirus infection in Iran. STUDY
DESIGN: One hundred and twenty-seven single sera from children up to 7 years of age, collected from healthy Iranian children in 1993-1994, were tested for antibodies to enteric adenoviruses by neutralization tests. RESULT AND
CONCLUSION: Antibodies to enteric adenoviruses have been detected in about one-half of sera. It is concluded that infection by these viruses is common among children in Iran.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720819     DOI: 10.1016/s1386-6532(99)00071-2

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  4 in total

1.  Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41.

Authors:  Franck Lemiale; Hedi Haddada; Gary J Nabel; Douglas E Brough; C Richter King; Jason G D Gall
Journal:  Vaccine       Date:  2006-11-28       Impact factor: 3.641

2.  Human adenovirus 52 uses sialic acid-containing glycoproteins and the coxsackie and adenovirus receptor for binding to target cells.

Authors:  Annasara Lenman; A Manuel Liaci; Yan Liu; Carin Årdahl; Anandi Rajan; Emma Nilsson; Will Bradford; Lisa Kaeshammer; Morris S Jones; Lars Frängsmyr; Ten Feizi; Thilo Stehle; Niklas Arnberg
Journal:  PLoS Pathog       Date:  2015-02-12       Impact factor: 6.823

Review 3.  Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs.

Authors:  Julio Alonso-Padilla; Tibor Papp; Győző L Kaján; Mária Benkő; Menzo Havenga; Angelique Lemckert; Balázs Harrach; Andrew H Baker
Journal:  Mol Ther       Date:  2015-10-19       Impact factor: 11.454

4.  Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions.

Authors:  Wei-Xiong Yang; Xiao-Hui Zou; Shuang-Ying Jiang; Nan-Nan Lu; Mei Han; Jian-Hai Zhao; Xiao-Juan Guo; Sheng-Cang Zhao; Zhuo-Zhuang Lu
Journal:  Vaccine       Date:  2016-11-04       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.